Abstract
We report a case of eczema-like cutaneous mucormycosis caused by Rhizopus arrhizus. A 4-year-old child was presented to our hospital with a history of gradually enlarging papule and plaque in the periumbilical area for nearly 4 years since 2 weeks after his birth, and it has been misdiagnosed as eczema for nearly 3 years. Based on histopathology examination, the fungus culture test and DNA sequencing, it was revealed that R. arrhizus should be the responsible fungus for skin infection. The patient was successfully cured by combination of intravenous drip and percutaneous injection amphotericin B for nearly 3 months, and no recrudescence was seen during a follow-up of 6-month observation.
Similar content being viewed by others
References
Binder U, Maurer E, Lass-Florl C. Mucormycosis—from the pathogens to the disease. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20(Suppl 6):60–6. https://doi.org/10.1111/1469-0691.12566.
Barratt DM, Van Meter K, Asmar P, Nolan T, Trahan C, Garcia-Covarrubias L, et al. Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model. Antimicrob Agents Chemother. 2001;45(12):3601–2. https://doi.org/10.1128/AAC.45.12.3601-3602.2001.
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53. https://doi.org/10.1086/432579.
Liang GZ, Xu WQ, Zheng XL, Mei H, Lv GX, Shen YN, et al. Successful treatment by surgery of a primary cutaneous mucormycosis caused by mucor irregularis. Mycopathologia. 2017. https://doi.org/10.1007/s11046-017-0219-4.
Lu XL, Liu ZH, Shen YN, She XD, Lu GX, Zhan P, et al. Primary cutaneous zygomycosis caused by rhizomucor variabilis: A new endemic zygomycosis? A case report and review of 6 cases reported from China. Clin Infect Dis. 2009;49(3):e39–43. https://doi.org/10.1086/600817.
CLSI. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved standard-Second Edition. CLSI document M38-A2. Wayne, PA: Clinical and Laborary Standards Institute; 2008.
Pana ZD, Seidel D, Skiada A, Groll AH, Petrikkos G, Cornely OA, et al. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. BMC Infect Dis. 2016;16(1):667. https://doi.org/10.1186/s12879-016-2005-1.
Sundararajan T, Kumar CPG, Menon T, Rekha K, Venkatadesikalu M. Cutaneous zygomycosis due to Rhizopus oryzae in a patient with acute lymphoblastic leukemia. Mycoses. 2004;47:521–3.
Zhang AP, Liu W, Hu B. Cutaneous mucormycosis due to Rhizopus arrhizus: report 3 cases. J Clin Dermatol. 2012;41(3):163–5 (in Chinese with English abstract).
Wattier RL, Dvorak CC, Hoffman JA, Brozovich AA, Bin-Hussain I, Groll AH, et al. A prospective, international cohort study of invasive mold infections in children. J Pediatr Infect Dis Soc. 2015;4(4):313–22. https://doi.org/10.1093/jpids/piu074.
Prasad PA, Vaughan AM, Zaoutis TE. Trends in zygomycosis in children. Mycoses. 2012;55(4):352–6. https://doi.org/10.1111/j.1439-0507.2011.02124.x.
Dabritz J, Attarbaschi A, Tintelnot K, Kollmar N, Kremens B, von Loewenich FD, et al. Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases. Mycoses. 2011;54(6):e785–8. https://doi.org/10.1111/j.1439-0507.2011.02025.x.
Rubin AI, Grossman ME. Bull’s-eye cutaneous infarct of zygomycosis: a bedside diagnosis confirmed by touch preparation. J Am Acad Dermatol. 2004;51(6):996–1001. https://doi.org/10.1016/j.jaad.2004.07.027.
Cantatore-Francis JL, Shin HT, Heilman E, Glick SA. Primary cutaneous zygomycosis in two immunocompromised children. Pediatr Dermatol. 2007;24(3):257–62. https://doi.org/10.1111/j.1525-1470.2007.00398.x.
Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20(Suppl 3):5–26. https://doi.org/10.1111/1469-0691.12371.
Martin LB, Rodriguez MAM, Mercier N, Lafont MO, Fernandez EO, de la Parte AR, et al. Rhizopus arrhizus invasive infection due to self-inflicted scratch injuries in a diabetic patient with non-ketotic acidosis. Mycopathologia. 2017;182(9–10):927–31. https://doi.org/10.1007/s11046-017-0158-0.
Zaoutis TE, Roilides E, Chiou CC, Buchanan WL, Knudsen TA, Sarkisova TA, et al. Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J. 2007;26(8):723–7. https://doi.org/10.1097/INF.0b013e318062115c.
Shoham S, Magill SS, Merz WG, Gonzalez C, Seibel N, Buchanan WL, et al. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases. Med Mycol. 2010;48(3):511–7. https://doi.org/10.3109/13693780903311944.
van Burik JAH, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis a retrospective summary. Clin Infect Dis. 2006;42:e61–5.
De Decker K, Van Poucke S, Wojciechowski M, Ieven M, Colpaert C, Vogelaers D, et al. Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2006;7(5):482–5. https://doi.org/10.1097/01.pcc.0000235255.68759.05.
Snaith J, Burns K, Kok J, Chen S, Cheung NW. A case of rhino-orbital mucormycosis in diabetes with haematogenous cerebral spread. Med Mycol Case Rep. 2016;13:22–4. https://doi.org/10.1016/j.mmcr.2016.10.002.
Wildenbeest JG, Oomen MW, Bruggemann RJ, de Boer M, Bijleveld Y, van den Berg JM, et al. Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease. Pediatr Infect Dis J. 2010;29(6):578. https://doi.org/10.1097/INF.0b013e3181dc8352.
Mushtaq S, Dogra D, Dogra N. Clinical response with intralesional amphotericin B in the treatment of old world cutaneous leishmaniasis: a preliminary report. Dermatol Ther. 2016;29(6):398–405. https://doi.org/10.1111/dth.12377.
Zhang DL. Nursing experience of one child with disseminated cryptococcosis. Sichuan Med J. 2005;26(6):697–8 (in Chinese).
Nikandish M, Goyonlo VM, Taheri AR, Kiafar B. Ocular leishmaniasis treated by intralesional amphotericin B. Middle East Afr J Ophthalmol. 2016;23(1):153–5. https://doi.org/10.4103/0974-9233.171801.
Goyonlo VM, Vosoughi E, Kiafar B, Nahidi Y, Momenzadeh A, Taheri AR. Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis. Indian J Dermatol. 2014;59(6):631. https://doi.org/10.4103/0019-5154.143571.
Vitale RG, de Hoog GS, Schwarz P, Dannaoui E, Deng S, Machouart M, et al. Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales. J Clin Microbiol. 2012;50(1):66–75. https://doi.org/10.1128/JCM.06133-11.
Acknowledgements
This study was funded by Special Program for Basic work of science and technology, funded by the Ministry of Science and Technology of China (2013FY113700), supported by National Natural Science Foundation of China (81471905) and was funded by the Chinese Academy Medical Sciences Initiative for Innovative Medicine (2016-I2M-3-021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Handling Editor: Yuping Ran.
Mei-hua Fu and Jia Liu have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Fu, Mh., Liu, J., Liang, Gz. et al. Successful Treatment of Eczema-Like Mucormycosis in a Child by Combination of Intravenous Drip and Percutaneous Injection Amphotericin B. Mycopathologia 184, 309–313 (2019). https://doi.org/10.1007/s11046-018-0273-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-018-0273-6